KWA
ELV icon

KCS Wealth Advisory’s Elevance Health ELV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$2.93M Buy
6,727
+248
+4% +$108K 1.25% 21
2023
Q2
$2.88M Buy
6,479
+497
+8% +$221K 1% 30
2023
Q1
$2.75M Buy
5,982
+652
+12% +$300K 1.04% 30
2022
Q4
$2.73M Buy
5,330
+137
+3% +$70.3K 1.14% 25
2022
Q3
$2.36M Buy
5,193
+513
+11% +$233K 1.09% 27
2022
Q2
$2.26M Buy
4,680
+112
+2% +$54K 1% 31
2022
Q1
$2.24M Buy
4,568
+164
+4% +$80.6K 1.04% 31
2021
Q4
$2.04M Buy
4,404
+1,247
+39% +$578K 0.82% 36
2021
Q3
$1.18M Buy
3,157
+98
+3% +$36.5K 0.56% 62
2021
Q2
$1.17M Buy
3,059
+63
+2% +$24.1K 0.55% 64
2021
Q1
$1.08M Buy
2,996
+247
+9% +$88.6K 0.56% 66
2020
Q4
$883K Buy
2,749
+111
+4% +$35.7K 0.58% 67
2020
Q3
$709K Buy
2,638
+89
+3% +$23.9K 0.57% 71
2020
Q2
$670K Buy
2,549
+61
+2% +$16K 0.55% 71
2020
Q1
$565K Buy
2,488
+293
+13% +$66.5K 0.57% 70
2019
Q4
$663K Buy
2,195
+59
+3% +$17.8K 0.5% 87
2019
Q3
$513K Buy
2,136
+119
+6% +$28.6K 0.35% 102
2019
Q2
$569K Buy
2,017
+377
+23% +$106K 0.45% 92
2019
Q1
$471K Buy
1,640
+295
+22% +$84.7K 0.41% 100
2018
Q4
$353K Buy
1,345
+108
+9% +$28.3K 0.37% 109
2018
Q3
$339K Buy
1,237
+133
+12% +$36.4K 0.31% 115
2018
Q2
$263K Buy
1,104
+55
+5% +$13.1K 0.25% 133
2018
Q1
$230K Buy
+1,049
New +$230K 0.21% 145